For your patients initiating treatment with an investigational drug in an Expanded Access Program (EAP),
FUZEON ASAP gives you the opportunity to start them on FUZEON at the same time.
- An immediate shipment of a 30-day supply at no cost to patient or clinician
- Up to two additional 30-day supplies if reimbursement is still pending
- A comprehensive network of support services committed to patient success with FUZEON
- Reimbursement assistance services to help evaluate and verify reimbursement
options, assist with required prior authorizations and provide an application to
the Roche Patient Assistance Program (PAP),* if needed
- Specially trained nurses provide in home, individualized instruction to help patients start and stay on treatment
Simply complete and fax the
FUZEON ASAP enrollment form.
If you have additional questions, please call the FUZEON Connections Center at 877-4FUZEON (877-438-9366).
* Roche PAP provides products to patients who do not have prescription drug coverage and do not qualify for government-funded programs. Applicants are considered on an individual basis and must meet Roche PAP eligibility guidelines. Not all patients will qualify for assistance.
Roche and Trimeris reserve the right to discontinue or restrict enrollment in FUZEON ASAP at any time